These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36372271)

  • 1. Current approaches to facilitate improved drug delivery to the central nervous system.
    Markowicz-Piasecka M; Darłak P; Markiewicz A; Sikora J; Kumar Adla S; Bagina S; Huttunen KM
    Eur J Pharm Biopharm; 2022 Dec; 181():249-262. PubMed ID: 36372271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches to enhance CNS delivery of drugs across the brain barriers.
    Lu CT; Zhao YZ; Wong HL; Cai J; Peng L; Tian XQ
    Int J Nanomedicine; 2014; 9():2241-57. PubMed ID: 24872687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.
    Ansari MA; Chung IM; Rajakumar G; Alzohairy MA; Alomary MN; Thiruvengadam M; Pottoo FH; Ahmad N
    Curr Pharm Des; 2020; 26(11):1128-1137. PubMed ID: 31951165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructure-based drug delivery systems for brain targeting.
    Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
    Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent expansions of novel strategies towards the drug targeting into the brain.
    Alexander A; Agrawal M; Uddin A; Siddique S; Shehata AM; Shaker MA; Ata Ur Rahman S; Abdul MIM; Shaker MA
    Int J Nanomedicine; 2019; 14():5895-5909. PubMed ID: 31440051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.
    Song YH; De R; Lee KT
    Adv Colloid Interface Sci; 2023 Oct; 320():103008. PubMed ID: 37776736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
    Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
    Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
    Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
    J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.